SCHEMBL24802484

SCHEMBL24802484

COc1ncc(C)cc1CC#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC13A5 Q86YT5 3/20 0.44
SLC13A2 Q13183 1/20 0.44
SLC13A3 Q8WWT9 1/20 0.44
CYP3A4 P08684 4/20 0.34
CYP2C9 P11712 3/20 0.34
RECQL P46063 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
PIK3CG P48736 1/20 0.32
MAOA P21397 1/20 0.32
DYRK1A Q13627 1/20 0.32
FLT3 P36888 2/20 0.31
CSF1R P07333 1/20 0.31
KIT P10721 1/20 0.31
CYP2C19 P33261 1/20 0.31
KDR P35968 1/20 0.31
AURKC Q9UQB9 1/20 0.31
KDM4E B2RXH2 2/20 0.30
ALDH1A1 P00352 2/20 0.30
GAA P10253 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24802460 0.81 PIK3CG (0.32) PIK3CG
SCHEMBL21408261 0.81 CYP2C9 (0.38) CYP3A4CYP2C9PIK3CGFLT3CSF1R
SCHEMBL30434407 0.81 CYP2C9 (0.38) CYP3A4CYP2C9PIK3CGFLT3CSF1R
SCHEMBL12093547 0.78 SLC13A5 (0.51) SLC13A5SLC13A2SLC13A3CYP3A4CYP2C9
SCHEMBL24092341 0.77 SLC13A5 (0.47) SLC13A5SLC13A2SLC13A3CYP3A4CYP2C9
SCHEMBL20670339 0.77 SLC13A5 (0.47) SLC13A5SLC13A2SLC13A3CYP3A4CYP2C9
SCHEMBL5780868 0.77 SLC13A5 (0.50) SLC13A5SLC13A2SLC13A3CYP3A4CYP2C9
SCHEMBL5780686 0.77 SLC13A5 (0.50) SLC13A5SLC13A2SLC13A3CYP3A4CYP2C9
SCHEMBL22854614 0.75 AR (0.34) DYRK1AALDH1A1
SCHEMBL25554902 0.75 PIK3CD (0.33) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed